{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:17:51Z","timestamp":1790050671812,"version":"4.0.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL143697"],"award-info":[{"award-number":["P01HL143697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL143697"],"award-info":[{"award-number":["P01HL143697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL143697"],"award-info":[{"award-number":["P01HL143697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132516"],"award-info":[{"award-number":["R01HL132516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132516"],"award-info":[{"award-number":["R01HL132516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK109675"],"award-info":[{"award-number":["R01DK109675"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK109675"],"award-info":[{"award-number":["R01DK109675"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL131481"],"award-info":[{"award-number":["P01HL131481"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL131481"],"award-info":[{"award-number":["P01HL131481"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17SFRN33520045"],"award-info":[{"award-number":["17SFRN33520045"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>The cardiovascular complications of type 1 and 2 diabetes are major causes of morbidity and mortality. Extensive efforts have been made to maximize glycemic control; this strategy reduces certain manifestations of cardiovascular complications. There are drawbacks, however, as intensive glycemic control does not impart perennial protective benefits, and these efforts are not without potential adverse sequelae, such as hypoglycemic events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Here, the authors have focused on updates into key areas under study for mechanisms driving these cardiovascular disorders in diabetes, including roles for epigenetics and gene expression, interferon networks, and mitochondrial dysfunction. Updates on the cardioprotective roles of the new classes of hyperglycemia-targeting therapies, the sodium glucose transport protein 2 inhibitors and the agonists of the glucagon-like peptide 1 receptor system, are reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>In summary, insights from ongoing research and the cardioprotective benefits of the newer type 2 diabetes therapies are providing novel areas for therapeutic opportunities in diabetes and CVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-021-01504-4","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T05:06:35Z","timestamp":1622696795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Diabetes and Cardiovascular Complications: The Epidemics Continue"],"prefix":"10.1007","volume":"23","author":[{"given":"Raquel","family":"L\u00f3pez-D\u00edez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lander","family":"Ega\u00f1a-Gorro\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Senatus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Shekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravichandran","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8902-070X","authenticated-orcid":false,"given":"Ann Marie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"1504_CR1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2019","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels: International Diabetes Federation; 2019.","edition":"9"},{"issue":"3","key":"1504_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2337\/dc14-1432","volume":"38","author":"TM Abraham","year":"2015","unstructured":"Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: the Framingham Heart Study. Diabetes Care. 2015;38(3):482\u20137. https:\/\/doi.org\/10.2337\/dc14-1432.","journal-title":"Diabetes Care"},{"key":"1504_CR3","volume-title":"Diabetes and cardiovascular disease","author":"International Diabetes Federation","year":"2016","unstructured":"International Diabetes Federation. Diabetes and cardiovascular disease. Brussels: International Diabetes Federation; 2016."},{"issue":"9","key":"1504_CR4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/s2213-8587(20)30238-2","volume":"8","author":"M Apicella","year":"2020","unstructured":"Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782\u201392. https:\/\/doi.org\/10.1016\/s2213-8587(20)30238-2This reference is very important because it highlights that diabetes presents increased risk for the severity of SARS-CoV-2 infection.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"18","key":"1504_CR5","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2002032This reference is very important because it highlights that diabetes presents increased risk for the severity of SARS-CoV-2 infection.","journal-title":"N Engl J Med"},{"issue":"7","key":"1504_CR6","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/all.14238","volume":"75","author":"JJ Zhang","year":"2020","unstructured":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730\u201341. https:\/\/doi.org\/10.1111\/all.14238This reference is very important because it highlights that diabetes presents increased risk for the severity of SARS-CoV-2 infection.","journal-title":"Allergy"},{"issue":"10229","key":"1504_CR7","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(20)30566-3This reference is very important because it highlights that diabetes presents increased risk for the severity of SARS-CoV-2 infection.","journal-title":"Lancet"},{"issue":"6","key":"1504_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40618-020-01236-2","volume":"43","author":"GP Fadini","year":"2020","unstructured":"Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Investig. 2020;43(6):867\u20139. https:\/\/doi.org\/10.1007\/s40618-020-01236-2This reference is very important because it highlights that diabetes presents increased risk for the severity of SARS-CoV-2 infection.","journal-title":"J Endocrinol Investig"},{"issue":"9131","key":"1504_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837\u201353.","journal-title":"Lancet"},{"issue":"5","key":"1504_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/CIRCOUTCOMES.116.002901","volume":"9","author":"R Rodr\u00edguez-Guti\u00e9rrez","year":"2016","unstructured":"Rodr\u00edguez-Guti\u00e9rrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes. 2016;9(5):504\u201312. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.002901.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"24","key":"1504_CR11","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u201359. https:\/\/doi.org\/10.1056\/NEJMoa0802743.","journal-title":"N Engl J Med"},{"issue":"11","key":"1504_CR12","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.2337\/dc06-1161","volume":"29","author":"TJ Orchard","year":"2006","unstructured":"Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006;29(11):2528\u201338. https:\/\/doi.org\/10.2337\/dc06-1161.","journal-title":"Diabetes Care"},{"issue":"10","key":"1504_CR13","doi-asserted-by":"publisher","first-page":"e1001321","DOI":"10.1371\/journal.pmed.1001321","volume":"9","author":"SJ Livingstone","year":"2012","unstructured":"Livingstone SJ, Looker HC, Hothersall EJ, Wild SH, Lindsay RS, Chalmers J, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med. 2012;9(10):e1001321. https:\/\/doi.org\/10.1371\/journal.pmed.1001321.","journal-title":"PLoS Med"},{"issue":"25","key":"1504_CR14","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643\u201353. https:\/\/doi.org\/10.1056\/NEJMoa052187.","journal-title":"N Engl J Med"},{"issue":"1","key":"1504_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"DM Nathan","year":"2014","unstructured":"Nathan DM. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9\u201316. https:\/\/doi.org\/10.2337\/dc13-2112.","journal-title":"Diabetes Care"},{"key":"1504_CR16","doi-asserted-by":"publisher","first-page":"108591","DOI":"10.1016\/j.diabres.2020.108591","volume":"171","author":"I Bebu","year":"2020","unstructured":"Bebu I, Braffett BH, Orchard TJ, Lorenzi GM, Nathan DM, Herman WH, et al. Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: the DCCT\/EDIC study. Diabetes Res Clin Pract. 2020;171:108591. https:\/\/doi.org\/10.1016\/j.diabres.2020.108591.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"1504_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The DCCT Research Group","year":"1995","unstructured":"The DCCT Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968\u201383.","journal-title":"Diabetes."},{"issue":"6","key":"1504_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1056\/nejm200002103420603","volume":"342","author":"JM Lachin","year":"2000","unstructured":"Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342(6):381\u20139. https:\/\/doi.org\/10.1056\/nejm200002103420603.","journal-title":"N Engl J Med"},{"key":"1504_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2337\/db20-0311","volume":"69","author":"JM Lachin","year":"2020","unstructured":"Lachin JM, Nathan DM, Zinman B, Bebu I. Comment on Miller and Orchard: understanding metabolic memory: a tale of two studies. Diabetes. 2020;69:291\u20139. Diabetes. 2020;69(7):e7. https:\/\/doi.org\/10.2337\/db20-0311.","journal-title":"Diabetes"},{"issue":"21","key":"1504_CR20","doi-asserted-by":"publisher","first-page":"18347","DOI":"10.1074\/jbc.R110.205286","volume":"286","author":"Z-x Chen","year":"2011","unstructured":"Chen Z-x, Riggs AD. DNA methylation and demethylation in mammals. J Biol Chem. 2011;286(21):18347\u201353. https:\/\/doi.org\/10.1074\/jbc.R110.205286.","journal-title":"J Biol Chem"},{"issue":"6765","key":"1504_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41\u20135. https:\/\/doi.org\/10.1038\/47412.","journal-title":"Nature."},{"issue":"7","key":"1504_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484\u201392. https:\/\/doi.org\/10.1038\/nrg3230.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"1504_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693\u2013705. https:\/\/doi.org\/10.1016\/j.cell.2007.02.005.","journal-title":"Cell."},{"issue":"7143","key":"1504_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature05915","volume":"447","author":"SL Berger","year":"2007","unstructured":"Berger SL. The complex language of chromatin regulation during transcription. Nature. 2007;447(7143):407\u201312. https:\/\/doi.org\/10.1038\/nature05915.","journal-title":"Nature."},{"issue":"10","key":"1504_CR25","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1084\/jem.20081188","volume":"205","author":"A El-Osta","year":"2008","unstructured":"El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008;205(10):2409\u201317. https:\/\/doi.org\/10.1084\/jem.20081188.","journal-title":"J Exp Med"},{"issue":"8","key":"1504_CR26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/circresaha.112.266171","volume":"110","author":"J Okabe","year":"2012","unstructured":"Okabe J, Orlowski C, Balcerczyk A, Tikellis C, Thomas MC, Cooper ME, et al. Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circ Res. 2012;110(8):1067\u201376. https:\/\/doi.org\/10.1161\/circresaha.112.266171.","journal-title":"Circ Res"},{"issue":"26","key":"1504_CR27","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1073\/pnas.0803623105","volume":"105","author":"LM Villeneuve","year":"2008","unstructured":"Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A. 2008;105(26):9047\u201352. https:\/\/doi.org\/10.1073\/pnas.0803623105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"1504_CR28","doi-asserted-by":"publisher","first-page":"E3002","DOI":"10.1073\/pnas.1603712113","volume":"113","author":"Z Chen","year":"2016","unstructured":"Chen Z, Miao F, Paterson AD, Lachin JM, Zhang L, Schones DE, et al. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT\/EDIC type 1 diabetes cohort. Proc Natl Acad Sci U S A. 2016;113(21):E3002\u201311. https:\/\/doi.org\/10.1073\/pnas.1603712113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1504_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.pharep.2017.12.008","volume":"70","author":"A Kumar","year":"2018","unstructured":"Kumar A, Mittal R. Mapping Txnip: key connexions in progression of diabetic nephropathy. Pharmacol Rep. 2018;70(3):614\u201322. https:\/\/doi.org\/10.1016\/j.pharep.2017.12.008.","journal-title":"Pharmacol Rep"},{"key":"1504_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/dmso.S232221","volume":"13","author":"DZ Wondafrash","year":"2020","unstructured":"Wondafrash DZ, Nire'a AT, Tafere GG, Desta DM, Berhe DA, Zewdie KA. Thioredoxin-interacting protein as a novel potential therapeutic target in diabetes mellitus and its underlying complications. Diabetes Metab Syndr Obes. 2020;13:43\u201351. https:\/\/doi.org\/10.2147\/dmso.S232221.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1504_CR31","doi-asserted-by":"publisher","first-page":"9051481","DOI":"10.1155\/2018\/9051481","volume":"2018","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhong P, Xu Y, Wang B, Zhu T, Zhang W, et al. Differential expression of TXNIP isoforms in the peripheral leukocytes of patients with acute myocardial infarction. Dis Markers. 2018;2018:9051481\u20136. https:\/\/doi.org\/10.1155\/2018\/9051481.","journal-title":"Dis Markers"},{"issue":"2","key":"1504_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2015.05.020","volume":"241","author":"CH Byon","year":"2015","unstructured":"Byon CH, Han T, Wu J, Hui ST. Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice. Atherosclerosis. 2015;241(2):313\u201321. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.05.020.","journal-title":"Atherosclerosis."},{"issue":"4","key":"1504_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/circresaha.111.256362","volume":"110","author":"XQ Wang","year":"2012","unstructured":"Wang XQ, Nigro P, World C, Fujiwara K, Yan C, Berk BC. Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2. Circ Res. 2012;110(4):560\u20138. https:\/\/doi.org\/10.1161\/circresaha.111.256362.","journal-title":"Circ Res"},{"issue":"8","key":"1504_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s42255-020-0231-8","volume":"2","author":"Z Chen","year":"2020","unstructured":"Chen Z, Miao F, Braffett BH, Lachin JM, Zhang L, Wu X, et al. DNA methylation mediates development of HbA1c-associated complications in type 1 diabetes. Nat Metab. 2020;2(8):744\u201362. https:\/\/doi.org\/10.1038\/s42255-020-0231-8This reference indicates that DNA methylation plays key roles in the development of complications in type 1 diabetes and identifies some of the key genes predicted to play mediating roles in these complications.","journal-title":"Nat Metab"},{"issue":"7","key":"1504_CR35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell. 1999;97(7):889\u2013901. https:\/\/doi.org\/10.1016\/s0092-8674(00)80801-6.","journal-title":"Cell."},{"key":"1504_CR36","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3389\/fimmu.2020.01071","volume":"11","author":"DM Mossel","year":"2020","unstructured":"Mossel DM, Moganti K, Riabov V, Weiss C, Kopf S, Cordero J, et al. Epigenetic regulation of S100A9 and S100A12 expression in monocyte-macrophage system in hyperglycemic conditions. Front Immunol. 2020;11:1071. https:\/\/doi.org\/10.3389\/fimmu.2020.01071This reference indicates that key proinflammatory ligands, S100A9 and S100A12 in macrophages are regulated through epigenetic mechanisms in monocytes and macrophages.","journal-title":"Front Immunol"},{"issue":"7","key":"1504_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1152\/physiolgenomics.00001.2013","volume":"45","author":"F Miao","year":"2013","unstructured":"Miao F, Chen Z, Zhang L, Wang J, Gao H, Wu X, et al. RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles. Physiol Genomics. 2013;45(7):287\u201399. https:\/\/doi.org\/10.1152\/physiolgenomics.00001.2013.","journal-title":"Physiol Genomics"},{"issue":"7314","key":"1504_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nature09386","volume":"467","author":"M Heinig","year":"2010","unstructured":"Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, Lu H, et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature. 2010;467(7314):460\u20134. https:\/\/doi.org\/10.1038\/nature09386.","journal-title":"Nature."},{"issue":"3","key":"1504_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","volume":"32","author":"AC Codo","year":"2020","unstructured":"Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis. Cell Metab. 2020;32(3):437\u201346.e5. https:\/\/doi.org\/10.1016\/j.cmet.2020.07.007.","journal-title":"Cell Metab"},{"key":"1504_CR40","doi-asserted-by":"publisher","first-page":"613039","DOI":"10.3389\/fimmu.2020.613039","volume":"11","author":"A Zahid","year":"2020","unstructured":"Zahid A, Ismail H, Li B, Jin T. Molecular and structural basis of DNA sensors in antiviral innate immunity. Front Immunol. 2020;11:613039. https:\/\/doi.org\/10.3389\/fimmu.2020.613039.","journal-title":"Front Immunol"},{"key":"1504_CR41","doi-asserted-by":"publisher","unstructured":"Broggi A, Granucci F, Zanoni I. Type III interferons: balancing tissue tolerance and resistance to pathogen invasion. J Exp Med. 2020;217(1). https:\/\/doi.org\/10.1084\/jem.20190295.","DOI":"10.1084\/jem.20190295"},{"issue":"10","key":"1504_CR42","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00011-020-01382-6","volume":"69","author":"A Elyasi","year":"2020","unstructured":"Elyasi A, Voloshyna I, Ahmed S, Kasselman LJ, Behbodikhah J, De Leon J, et al. The role of interferon-\u03b3 in cardiovascular disease: an update. Inflamm Res. 2020;69(10):975\u201388. https:\/\/doi.org\/10.1007\/s00011-020-01382-6.","journal-title":"Inflamm Res"},{"issue":"6455","key":"1504_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/366583a0","volume":"366","author":"O Silvennoinen","year":"1993","unstructured":"Silvennoinen O, Ihle JN, Schlessinger J, Levy DE. Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature. 1993;366(6455):583\u20135. https:\/\/doi.org\/10.1038\/366583a0.","journal-title":"Nature."},{"issue":"Database issue","key":"1504_CR44","doi-asserted-by":"publisher","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","volume":"41","author":"I Rusinova","year":"2013","unstructured":"Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 2013;41(Database issue):D1040\u20136. https:\/\/doi.org\/10.1093\/nar\/gks1215.","journal-title":"Nucleic Acids Res"},{"key":"1504_CR45","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3389\/fimmu.2019.01253","volume":"10","author":"A Piaszyk-Borychowska","year":"2019","unstructured":"Piaszyk-Borychowska A, Sz\u00e9les L, Csermely A, Chiang HC, Weso\u0142y J, Lee CK, et al. Signal integration of IFN-I and IFN-II with TLR4 involves sequential recruitment of STAT1-complexes and NF\u03baB to enhance pro-inflammatory transcription. Front Immunol. 2019;10:1253. https:\/\/doi.org\/10.3389\/fimmu.2019.01253.","journal-title":"Front Immunol"},{"issue":"1","key":"1504_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tcm.2013.06.003","volume":"24","author":"I Voloshyna","year":"2014","unstructured":"Voloshyna I, Littlefield MJ, Reiss AB. Atherosclerosis and interferon-\u03b3: new insights and therapeutic targets. Trends Cardiovasc Med. 2014;24(1):45\u201351. https:\/\/doi.org\/10.1016\/j.tcm.2013.06.003.","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"1504_CR47","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","volume":"38","author":"P Libby","year":"2013","unstructured":"Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013;38(6):1092\u2013104. https:\/\/doi.org\/10.1016\/j.immuni.2013.06.009.","journal-title":"Immunity."},{"issue":"7333","key":"1504_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature09753","volume":"470","author":"O Harismendy","year":"2011","unstructured":"Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, et al. 9p21 DNA variants associated with coronary artery disease impair interferon-\u03b3 signalling response. Nature. 2011;470(7333):264\u20138. https:\/\/doi.org\/10.1038\/nature09753.","journal-title":"Nature."},{"issue":"3","key":"1504_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/circresaha.120.316903","volume":"127","author":"A Zernecke","year":"2020","unstructured":"Zernecke A, Winkels H, Cochain C, Williams JW, Wolf D, Soehnlein O, et al. Meta-Analysis of leukocyte diversity in atherosclerotic mouse aortas. Circ Res. 2020;127(3):402\u201326. https:\/\/doi.org\/10.1161\/circresaha.120.316903.","journal-title":"Circ Res"},{"issue":"10","key":"1504_CR50","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/j.celrep.2018.05.010","volume":"23","author":"CA Reardon","year":"2018","unstructured":"Reardon CA, Lingaraju A, Schoenfelt KQ, Zhou G, Cui C, Jacobs-El H, et al. Obesity and insulin resistance promote atherosclerosis through an IFN\u03b3-regulated macrophage protein network. Cell Rep. 2018;23(10):3021\u201330. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.010.","journal-title":"Cell Rep"},{"key":"1504_CR51","doi-asserted-by":"publisher","unstructured":"Senatus L, L\u00f3pez-D\u00edez R, Ega\u00f1a-Gorro\u00f1o L, Liu J, Hu J, Daffu G, et al. RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism. JCI Insight. 2020;5(13). https:\/\/doi.org\/10.1172\/jci.insight.137289This reference links macrophage expression of IRF7 to impaired regression of diabetic atherosclerosis in murine models.","DOI":"10.1172\/jci.insight.137289"},{"issue":"6","key":"1504_CR52","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.ajpath.2013.08.019","volume":"183","author":"N Gaudreault","year":"2013","unstructured":"Gaudreault N, Kumar N, Olivas VR, Eberl\u00e9 D, Stephens K, Raffai RL. Hyperglycemia impairs atherosclerosis regression in mice. Am J Pathol. 2013;183(6):1981\u201392. https:\/\/doi.org\/10.1016\/j.ajpath.2013.08.019.","journal-title":"Am J Pathol"},{"issue":"9","key":"1504_CR53","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.2337\/db18-0156","volume":"67","author":"C Yuan","year":"2018","unstructured":"Yuan C, Hu J, Parathath S, Grauer L, Cassella CB, Bagdasarov S, et al. Human aldose reductase expression prevents atherosclerosis regression in diabetic mice. Diabetes. 2018;67(9):1880\u201391. https:\/\/doi.org\/10.2337\/db18-0156.","journal-title":"Diabetes."},{"issue":"6","key":"1504_CR54","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2337\/db10-0778","volume":"60","author":"S Parathath","year":"2011","unstructured":"Parathath S, Grauer L, Huang LS, Sanson M, Distel E, Goldberg IJ, et al. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes. 2011;60(6):1759\u201369. https:\/\/doi.org\/10.2337\/db10-0778.","journal-title":"Diabetes."},{"issue":"9","key":"1504_CR55","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/atvbaha.114.304144","volume":"34","author":"C Recio","year":"2014","unstructured":"Recio C, Oguiza A, Lazaro I, Mallavia B, Egido J, Gomez-Guerrero C. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase\/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice. Arterioscler Thromb Vasc Biol. 2014;34(9):1953\u201360. https:\/\/doi.org\/10.1161\/atvbaha.114.304144.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1504_CR56","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nri2093","volume":"7","author":"A Yoshimura","year":"2007","unstructured":"Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7(6):454\u201365. https:\/\/doi.org\/10.1038\/nri2093.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1504_CR57","first-page":"1","volume":"2","author":"MC Trengove","year":"2013","unstructured":"Trengove MC, Ward AC. SOCS proteins in development and disease. Am J Clin Exp Immunol. 2013;2(1):1\u201329.","journal-title":"Am J Clin Exp Immunol"},{"issue":"3","key":"1504_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0002-9343(55)90218-7","volume":"18","author":"I Ungar","year":"1955","unstructured":"Ungar I, Gilbert M, Siegel A, Blain JM, Bing RJ. Studies on myocardial metabolism. IV. Myocardial metabolism in diabetes. Am J Med. 1955;18(3):385\u201396. https:\/\/doi.org\/10.1016\/0002-9343(55)90218-7.","journal-title":"Am J Med"},{"issue":"4","key":"1504_CR59","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660\u201371. https:\/\/doi.org\/10.1007\/s00125-014-3171-6.","journal-title":"Diabetologia."},{"issue":"10","key":"1504_CR60","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.2337\/db19-1057","volume":"69","author":"AR Wende","year":"2020","unstructured":"Wende AR, Schell JC, Ha CM, Pepin ME, Khalimonchuk O, Schwertz H, et al. Maintaining myocardial glucose utilization in diabetic cardiomyopathy accelerates mitochondrial dysfunction. Diabetes. 2020;69(10):2094\u2013111. https:\/\/doi.org\/10.2337\/db19-1057.","journal-title":"Diabetes."},{"issue":"16","key":"1504_CR61","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1161\/circulationaha.118.033552","volume":"139","author":"S Wu","year":"2019","unstructured":"Wu S, Lu Q, Ding Y, Wu Y, Qiu Y, Wang P, et al. Hyperglycemia-driven inhibition of AMP-activated protein kinase \u03b12 induces diabetic cardiomyopathy by promoting mitochondria-associated endoplasmic reticulum membranes in vivo. Circulation. 2019;139(16):1913\u201336. https:\/\/doi.org\/10.1161\/circulationaha.118.033552.","journal-title":"Circulation."},{"issue":"2","key":"1504_CR62","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1096\/fj.201901838R","volume":"34","author":"L Tao","year":"2020","unstructured":"Tao L, Huang X, Xu M, Yang L, Hua F. MiR-144 protects the heart from hyperglycemia-induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis. FASEB J. 2020;34(2):2173\u201397. https:\/\/doi.org\/10.1096\/fj.201901838R.","journal-title":"FASEB J"},{"issue":"1","key":"1504_CR63","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41467-017-00664-8","volume":"8","author":"W Liu","year":"2017","unstructured":"Liu W, Ruiz-Velasco A, Wang S, Khan S, Zi M, Jungmann A, et al. Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling. Nat Commun. 2017;8(1):494. https:\/\/doi.org\/10.1038\/s41467-017-00664-8.","journal-title":"Nat Commun"},{"issue":"6","key":"1504_CR64","doi-asserted-by":"publisher","first-page":"C732","DOI":"10.1152\/ajpcell.00350.2017","volume":"314","author":"M Pan","year":"2018","unstructured":"Pan M, Han Y, Basu A, Dai A, Si R, Willson C, et al. Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice. Am J Physiol Cell Physiol. 2018;314(6):C732\u2013c40. https:\/\/doi.org\/10.1152\/ajpcell.00350.2017.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"1504_CR65","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1161\/circulationaha.110.014506","volume":"124","author":"SM Shenouda","year":"2011","unstructured":"Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation. 2011;124(4):444\u201353. https:\/\/doi.org\/10.1161\/circulationaha.110.014506.","journal-title":"Circulation."},{"issue":"1","key":"1504_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/db16-0915","volume":"66","author":"Q Wang","year":"2017","unstructured":"Wang Q, Zhang M, Torres G, Wu S, Ouyang C, Xie Z, et al. Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of Drp1-mediated mitochondrial fission. Diabetes. 2017;66(1):193\u2013205. https:\/\/doi.org\/10.2337\/db16-0915.","journal-title":"Diabetes."},{"issue":"1","key":"1504_CR67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12933-020-01130-4","volume":"19","author":"AZ Chase-Vilchez","year":"2020","unstructured":"Chase-Vilchez AZ, Chan IHY, Peters SAE, Woodward M. Diabetes as a risk factor for incident peripheral arterial disease in women compared to men: a systematic review and meta-analysis. Cardiovasc Diabetol. 2020;19(1):151. https:\/\/doi.org\/10.1186\/s12933-020-01130-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"1504_CR68","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/atvbaha.120.314595","volume":"40","author":"JA Barnes","year":"2020","unstructured":"Barnes JA, Eid MA, Creager MA, Goodney PP. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(8):1808\u201317. https:\/\/doi.org\/10.1161\/atvbaha.120.314595.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1504_CR69","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2010.11.012","volume":"12","author":"SL Williams","year":"2010","unstructured":"Williams SL, Huang J, Edwards YJ, Ulloa RH, Dillon LM, Prolla TA, et al. The mtDNA mutation spectrum of the progeroid Polg mutator mouse includes abundant control region multimers. Cell Metab. 2010;12(6):675\u201382. https:\/\/doi.org\/10.1016\/j.cmet.2010.11.012.","journal-title":"Cell Metab"},{"key":"1504_CR70","doi-asserted-by":"publisher","unstructured":"Ryan TE, Schmidt CA, Tarpey MD, Amorese AJ, Yamaguchi DJ, Goldberg EJ, et al. PFKFB3-mediated glycolysis rescues myopathic outcomes in the ischemic limb. JCI Insight. 2020;5(18). https:\/\/doi.org\/10.1172\/jci.insight.139628.","DOI":"10.1172\/jci.insight.139628"},{"issue":"2","key":"1504_CR71","doi-asserted-by":"publisher","first-page":"H333","DOI":"10.1152\/ajpheart.01012.2008","volume":"296","author":"R Ananthakrishnan","year":"2009","unstructured":"Ananthakrishnan R, Kaneko M, Hwang YC, Quadri N, Gomez T, Li Q, et al. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol. 2009;296(2):H333\u201341. https:\/\/doi.org\/10.1152\/ajpheart.01012.2008.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"1504_CR72","doi-asserted-by":"publisher","first-page":"H297","DOI":"10.1152\/ajpheart.00999.2011","volume":"303","author":"M Abdillahi","year":"2012","unstructured":"Abdillahi M, Ananthakrishnan R, Vedantham S, Shang L, Zhu Z, Rosario R, et al. Aldose reductase modulates cardiac glycogen synthase kinase-3\u03b2 phosphorylation during ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2012;303(3):H297\u2013308. https:\/\/doi.org\/10.1152\/ajpheart.00999.2011.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"1504_CR73","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/circulationaha.105.575993","volume":"113","author":"LG Bucciarelli","year":"2006","unstructured":"Bucciarelli LG, Kaneko M, Ananthakrishnan R, Harja E, Lee LK, Hwang YC, et al. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury. Circulation. 2006;113(9):1226\u201334. https:\/\/doi.org\/10.1161\/circulationaha.105.575993.","journal-title":"Circulation."},{"issue":"7","key":"1504_CR74","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2337\/db07-0326","volume":"57","author":"LG Bucciarelli","year":"2008","unstructured":"Bucciarelli LG, Ananthakrishnan R, Hwang YC, Kaneko M, Song F, Sell DR, et al. RAGE and modulation of ischemic injury in the diabetic myocardium. Diabetes. 2008;57(7):1941\u201351. https:\/\/doi.org\/10.2337\/db07-0326.","journal-title":"Diabetes."},{"issue":"17","key":"1504_CR75","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1161\/circulationaha.118.038868","volume":"139","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RHM, et al. Comparison of the effects of Glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus. Circulation. 2019;139(17):2022\u201331. https:\/\/doi.org\/10.1161\/circulationaha.118.038868This reference reviews the effects of SGLT2 inhibitors and GLP1 receptor agonists on cardiovascular complications in diabetes.","journal-title":"Circulation"},{"issue":"11","key":"1504_CR76","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.5551\/jat.52100","volume":"27","author":"A Rahadian","year":"2020","unstructured":"Rahadian A, Fukuda D, Salim HM, Yagi S, Kusunose K, Yamada H, et al. Canagliflozin prevents diabetes-induced vascular dysfunction in ApoE-deficient mice. J Atheroscler Thromb. 2020;27(11):1141\u201351. https:\/\/doi.org\/10.5551\/jat.52100.","journal-title":"J Atheroscler Thromb"},{"key":"1504_CR77","doi-asserted-by":"publisher","first-page":"6305735","DOI":"10.1155\/2016\/6305735","volume":"2016","author":"W Leng","year":"2016","unstructured":"Leng W, Ouyang X, Lei X, Wu M, Chen L, Wu Q, et al. The SGLT-2 inhibitor dapagliflozin has a therapeutic effect on atherosclerosis in diabetic apoE(-\/-) mice. Mediat Inflamm. 2016;2016:6305735\u201313. https:\/\/doi.org\/10.1155\/2016\/6305735.","journal-title":"Mediat Inflamm"},{"key":"1504_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bcp.2018.03.013","volume":"152","author":"C Xu","year":"2018","unstructured":"Xu C, Wang W, Zhong J, Lei F, Xu N, Zhang Y, et al. Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells. Biochem Pharmacol. 2018;152:45\u201359. https:\/\/doi.org\/10.1016\/j.bcp.2018.03.013.","journal-title":"Biochem Pharmacol"},{"key":"1504_CR79","doi-asserted-by":"publisher","first-page":"106779","DOI":"10.1016\/j.vph.2020.106779","volume":"133-134","author":"Y Kang","year":"2020","unstructured":"Kang Y, Zhan F, He M, Liu Z, Song X. Anti-inflammatory effects of sodium-glucose co-transporter 2 inhibitors on atherosclerosis. Vasc Pharmacol. 2020;133-134:106779. https:\/\/doi.org\/10.1016\/j.vph.2020.106779.","journal-title":"Vasc Pharmacol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01504-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-021-01504-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01504-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:47:25Z","timestamp":1625640445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-021-01504-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1504"],"URL":"https:\/\/doi.org\/10.1007\/s11886-021-01504-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"14 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Schmidt and Ramasamy report a patent US 9,353,3078 issued, a patent US 9,364,472 issued, a patent US 16\/094270 pending, and a patent Europe 177,864,360.0 pending applications assigned to NYU Grossman School of Medicine. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"74"}}